Lv, L.; Maimaitiming, M.; Yang, J.; Xia, S.; Li, X.; Wang, P.; Liu, Z.; Wang, C.-Y.
Quinazolinone Derivative MR2938 Protects DSS-Induced Barrier Dysfunction in Mice Through Regulating Gut Microbiota. Pharmaceuticals 2025, 18, 123.
https://doi.org/10.3390/ph18010123
AMA Style
Lv L, Maimaitiming M, Yang J, Xia S, Li X, Wang P, Liu Z, Wang C-Y.
Quinazolinone Derivative MR2938 Protects DSS-Induced Barrier Dysfunction in Mice Through Regulating Gut Microbiota. Pharmaceuticals. 2025; 18(1):123.
https://doi.org/10.3390/ph18010123
Chicago/Turabian Style
Lv, Ling, Mireguli Maimaitiming, Jichen Yang, Shuli Xia, Xin Li, Pingyuan Wang, Zhiqing Liu, and Chang-Yun Wang.
2025. "Quinazolinone Derivative MR2938 Protects DSS-Induced Barrier Dysfunction in Mice Through Regulating Gut Microbiota" Pharmaceuticals 18, no. 1: 123.
https://doi.org/10.3390/ph18010123
APA Style
Lv, L., Maimaitiming, M., Yang, J., Xia, S., Li, X., Wang, P., Liu, Z., & Wang, C.-Y.
(2025). Quinazolinone Derivative MR2938 Protects DSS-Induced Barrier Dysfunction in Mice Through Regulating Gut Microbiota. Pharmaceuticals, 18(1), 123.
https://doi.org/10.3390/ph18010123
